SPI Pharma completes acquisition of Elementis Pharma
Deal expands SPI Pharma’s manufacturing footprint in Germany, enhances pharmaceutical ingredient offerings, and reinforces focus on fast-growing digestive health market
Deal expands SPI Pharma’s manufacturing footprint in Germany, enhances pharmaceutical ingredient offerings, and reinforces focus on fast-growing digestive health market
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy
Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
The graduating cohort comprised seven batches across five specialized programs
The newly commissioned facility strengthens the ’company’s capabilities in the development and manufacturing of generic and complex sterile injectable products
Premium CBD+THC-infused gummies target stress relief, relaxation, and sleep recovery
Subscribe To Our Newsletter & Stay Updated